Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 01 570.7 |
96 | EP file number | EAKZ | 99 96 8627.2 |
86 | WO file number | WAKZ | PCT/US99/20967 |
97 | EP publication number | EPN | 1109558 |
87 | WO publication number | WPN | 2000013686 |
54 | Designation/title | TI | RANOLAZINHALTIGE ARZNEIMITTEL MIT VERZÖGERTER WIRKSTOFFABGABE |
51 | IPC main class | ICM (ICMV) | A61K 31/495 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 9/20 (2006.01) |
22 | DE application date | DAT | Sep 9, 1999 |
96 | EP application date | EAT | Sep 9, 1999 |
86 | WO application date | WAT | Sep 9, 1999 |
43 | Date of first publication | OT | Mar 16, 2000 |
| Date of publication of grant | PET | May 22, 2002 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., (n.d.Ges.d. Staates Delaware), Foster City, Calif., US |
72 | Inventor | IN | WOLFF A., Andrew, San Francisco, US; BAKER, Fiona, Dunfermline KY11 4LE, GB; LANGRIDGE, John, Llandegla, Wrexham, GB |
74 | Representative | VTR | Zwicker Schnappauf & Partner Patentanwälte PartG mbB, 80686 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069901570T2 Searchable text:
DE000069901570T2 |
| Address for service | | Zwicker Schnappauf & Partner Patentanwälte PartG mbB, 80686 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 321522 May 27, 1999
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 99804 P Sep 10, 1998
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2008 000 065.3 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
81 | Designated WO countries | WDS | LT, SI, AL, LV, MK, RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001109558 Searchable text:
EP000001109558 Original document:
EP000001109558B1 Searchable text:
EP000001109558B1 Original document:
WO002000013686 Searchable text:
WO002000013686 |
43 | Date of first publication | EVT | Mar 16, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jul 13, 2023 (Show all update days)(Hide all update days)- Jul 13, 2023; Jun 2, 2023; Jun 1, 2023; Sep 11, 2019; Sep 5, 2019; Aug 20, 2019; Feb 21, 2019; Nov 29, 2018; Oct 23, 2018; Oct 5, 2018; Oct 11, 2017; Oct 15, 2016; Mar 19, 2016; Oct 16, 2015; Oct 9, 2015; Mar 27, 2015; Oct 22, 2014; Oct 9, 2014; Oct 16, 2013; Oct 9, 2013; Jan 23, 2013; Oct 17, 2012; Oct 9, 2012
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Dec 17, 2008 |
| Issue number | HN | 9 |
| Year | PJ | 2009 |
| Publication date | VT | Feb 26, 2009 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Roche Palo Alto LLC, Palo Alto, Calif., US |
71/73 | Previous applicant/owner | INHF | CV Therapeutics, Inc., Palo Alto, Calif., US, Syntex (U.S.A.) Inc., Palo Alto, Calif., US |